:

Homeland Security

Osiris Nabs $225M DoD Contract for Acute Radiation Syndrome

DDN

Wednesday, January 9th, 2008

SHARE:

Osiris Therapeutics [OSIR] won a potential $224.7 million contract from the Defense Department for the development and possible purchase of Prochymal, an adult stem cell therapy, for the repair of gastrointestinal injury resulting from radiation exposure. Initially Osiris will receive $4.2 million this year to continue development of Prochymal for acute radiation syndrome (ARS). Once the Food and Drug Administration (FDA) approves the drug for ARS, the contract provides for the purchase of up to 20,000 doses, at $10,000 per…

Congress

House Appropriators Unveil $1.07 Trillion FY ‘27 Defense Bill, Restore Funds For E-7, Army Aviation

House appropriators on Wednesday released their $1.07 trillion fiscal year 2027 defense spending bill, with the legislation reversing Army aviation cuts, restoring funding for the Air Force’s E-7 Wedgetail program […]

Congress

MOSA Implementation By Pentagon Lagging, GAO Official Says

While the Modular Open Systems Approach (MOSA) has been a requirement for major defense acquisition programs since January 2019 and other Defense Department acquisitions since January 2021, few programs are […]

Congress

HASC Wants Info On Army’s Plans To Pursue Autonomous Aerial Delivery, Surface Vessels For Logistics

The House Armed Services Committee (HASC) added several measures to its version of the next defense policy bill seeking more details from the Army on efforts to develop future logistics […]

Congress

McConnell: “Safe To Conclude There Will Not Be A Third Reconciliation Bill”

Two top GOP senators on the Senate Appropriations Committee are opposing a third reconciliation bill. The Trump administration’s total $1.5 trillion fiscal year 2027 defense request is split between $1.15 […]